1-20 of 23
screening
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder

Makoto Osada, Keiko Maruyama, Koichi Kokame, Ryunosuke Denda, Kohei Yamazaki, Hisako Kunieda, Maki Hirao, Seiji Madoiwa, Nobuo Okumura, Mitsuru Murata, Yasuo Ikeda, Kentaro Watanabe, Yuiko Tsukada, Takahide Kikuchi
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3830–3838.
https://doi.org/10.1182/bloodadvances.2020003814
Published: 2021
Journal Articles

Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia

Clinical Trials & Observations
Cécile Tomowiak, Stéphanie Poulain, Charles Herbaux, Aurore Perrot, Béatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, Delphine Nollet, Damien Roos-Weil, Sylvie Chevret, Véronique Leblond
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2438–2446.
https://doi.org/10.1182/bloodadvances.2020003895
Published: 2021
Includes: Supplemental data
Journal Articles

SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3 -ITD–mutant AML

Suruchi Pacharne, Oliver M. Dovey, Jonathan L. Cooper, Muxin Gu, Mathias J. Friedrich, Sandeep S. Rajan, Maxim Barenboim, Grace Collord, M. S. Vijayabaskar, Hannes Ponstingl, Etienne De Braekeleer, Ruben Bautista, Milena Mazan, Roland Rad, Konstantinos Tzelepis, Penny Wright, Malgorzata Gozdecka, George S. Vassiliou
Journal: Blood Advances
Blood Adv (2021) 5 (9): 2412–2425.
https://doi.org/10.1182/bloodadvances.2020003443
Published: 2021
Includes: Supplemental data
Journal Articles

Deciphering the mechanisms of CC-122 resistance in DLBCL via a genome-wide CRISPR screen

Zhongying Mo, Scott Wood, Shawn Namiranian, Reina Mizukoshi, Stephanie Weng, In Sock Jang, Celia Fontanillo, Joshua M. Baughman, Arianna Silva-Torres, Michelle Slade, Marwa Khater, Kai Wang, Mark Rolfe, Gang Lu
Journal: Blood Advances
Blood Adv (2021) 5 (7): 2027–2039.
https://doi.org/10.1182/bloodadvances.2020003431
Published: 2021
Includes: Supplemental data
Journal Articles

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax

Blake S. Moses, Samantha McCullough, Jennifer M. Fox, Bryan T. Mott, Søren M. Bentzen, MinJung Kim, Jeffrey W. Tyner, Rena G. Lapidus, Ashkan Emadi, Michelle A. Rudek, Tami J. Kingsbury, Curt I. Civin
Journal: Blood Advances
Blood Adv (2021) 5 (3): 711–724.
https://doi.org/10.1182/bloodadvances.2020003429
Published: 2021
Includes: Supplemental data
Journal Articles

Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism

Juan José Yepes-Nuñez, Anita Rajasekhar, Maryam Rahman, Philipp Dahm, David R. Anderson, Luis Enrique Colunga-Lozano, Stephanie Ross, Meha Bhatt, Kelly Estrada Orozco, Federico Popoff, Matthew Ventresca, Angela M. Barbara, Sara Balduzzi, Housne Begum, Arnav Agarwal, Wojtek Wiercioch, Robby Nieuwlaat, Gian Paolo Morgano, Holger J. Schünemann
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2798–2809.
https://doi.org/10.1182/bloodadvances.2020002195
Published: 2020
Includes: Supplemental data
Journal Articles

American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults

M. R. DeBaun, L. C. Jordan, A. A. King, J. Schatz, E. Vichinsky, C. K. Fox, R. C. McKinstry, P. Telfer, M. A. Kraut, L. Daraz, F. J. Kirkham, M. H. Murad
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1554–1588.
https://doi.org/10.1182/bloodadvances.2019001142
Published: 2020
Includes: Supplemental data
Journal Articles

Stem cell donors should be screened for CHIP

Amy E. DeZern, Lukasz P. Gondek
Journal: Blood Advances
Blood Adv (2020) 4 (4): 784–788.
https://doi.org/10.1182/bloodadvances.2019000394
Published: 2020
Journal Articles

Stem cell donors should not be screened for clonal hematopoiesis

Christopher J. Gibson, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2020) 4 (4): 789–792.
https://doi.org/10.1182/bloodadvances.2019000395
Published: 2020
Journal Articles

Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia

Haydar Çelik, Katherine E. Lindblad, Bogdan Popescu, Gege Gui, Meghali Goswami, Janet Valdez, Christin DeStefano, Catherine Lai, Julie Thompson, Jack Y. Ghannam, Giovanna Fantoni, Angélique Biancotto, Julián Candia, Foo Cheung, Gauthaman Sukumar, Clifton L. Dalgard, Richard H. Smith, Andre Larochelle, Laura W. Dillon, Christopher S. Hourigan
Journal: Blood Advances
Blood Adv (2020) 4 (2): 367–379.
https://doi.org/10.1182/bloodadvances.2019001124
Published: 2020
Includes: Supplemental data
Journal Articles

American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease

Robert I. Liem, Sophie Lanzkron, Thomas D. Coates, Laura DeCastro, Ankit A. Desai, Kenneth I. Ataga, Robyn T. Cohen, Johnson Haynes, Jr, Ifeyinwa Osunkwo, Jeffrey D. Lebensburger, James P. Lash, Theodore Wun, Madeleine Verhovsek, Elodie Ontala, Rae Blaylark, Fares Alahdab, Abdulrahman Katabi, Reem A. Mustafa
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3867–3897.
https://doi.org/10.1182/bloodadvances.2019000916
Published: 2019
Includes: Supplemental data
Journal Articles

2019 sickle cell disease guidelines by the American Society of Hematology: methodology, challenges, and innovations

M. Hassan Murad, Robert I. Liem, Eddy S. Lang, Elie A. Akl, Joerg J. Meerpohl, Michael R. DeBaun, John F. Tisdale, Amanda M. Brandow, Sophie M. Lanzkron, Stella T. Chou, Starr Webb, Reem A. Mustafa
Journal: Blood Advances
Blood Adv (2019) 3 (23): 3945–3950.
https://doi.org/10.1182/bloodadvances.2019000931
Published: 2019
Journal Articles

Building capacity to reduce stroke in children with sickle cell anemia in the Dominican Republic: the SACRED trial

Luisanna M. Sánchez, Rosa M. Nieves, Teresa Latham, Susan Stuber, Judy R. Luden, Gabriela S. Urcuyo, Melissa E. Berges, Carla Florencio, Carla Gonzalez, Paola del Villar, Adam Lane, William Schultz, Neelum Jeste, Rafael Mena, Russell E. Ware
Journal: Blood Advances
Blood Adv (2018) 2 (Supplement_1): 50–53.
https://doi.org/10.1182/bloodadvances.2018GS110818
Published: 2018
Journal Articles

Building a sickle cell disease screening program in the Republic of Uganda: the Uganda Sickle Surveillance Study (US3) with 3 years of follow-up screening results

Charles Kiyaga, Arielle G. Hernandez, Isaac Ssewanyana, Kathryn E. McElhinney, Grace Ndeezi, Thad A. Howard, Christopher M. Ndugwa, Russell E. Ware, Jane R. Aceng
Journal: Blood Advances
Blood Adv (2018) 2 (Supplement_1): 4–7.
https://doi.org/10.1182/bloodadvances.2018GS110951
Published: 2018
Journal Articles

Impact of somatic and germline mutations on the outcome of systemic mastocytosis

Clinical Trials & Observations
Javier I. Muñoz-González, María Jara-Acevedo, Iván Alvarez-Twose, Jason D. Merker, Cristina Teodosio, Yanli Hou, Ana Henriques, Krishna M. Roskin, Laura Sanchez-Muñoz, Albert G. Tsai, Carolina Caldas, Almudena Matito, J. Ignacio Sánchez-Gallego, Andrea Mayado, Noelia Dasilva-Freire, Jason R. Gotlib, Luis Escribano, Alberto Orfao, Andrés C. García-Montero
Journal: Blood Advances
Blood Adv (2018) 2 (21): 2814–2828.
https://doi.org/10.1182/bloodadvances.2018020628
Published: 2018
Includes: Supplemental data
Journal Articles

Molecular pathophysiology of the myelodysplastic syndromes: insights for targeted therapy

Clinical Trials & Observations
Alex Aleshin, Peter L. Greenberg
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2787–2797.
https://doi.org/10.1182/bloodadvances.2018015834
Published: 2018
Journal Articles

In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1 + BCP-ALL

Eleanor R. C. Fiedler, Arjun Bhutkar, Emily Lawler, Rana Besada, Michael T. Hemann
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1229–1242.
https://doi.org/10.1182/bloodadvances.2017015610
Published: 2018
Includes: Supplemental data
Journal Articles

Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease

Clinical Trials & Observations
Margaret T. Lee, Meyer Kattan, Ilene Fennoy, Stephen M. Arpadi, Rachel L. Miller, Serge Cremers, Donald J. McMahon, Jeri W. Nieves, Gary M. Brittenham
Journal: Blood Advances
Blood Adv (2018) 2 (9): 969–978.
https://doi.org/10.1182/bloodadvances.2017013979
Published: 2018
Includes: Supplemental data
Journal Articles

Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL

Kathryn G. Roberts, Yung-Li Yang, Debbie Payne-Turner, Wenwei Lin, Jacob K. Files, Kirsten Dickerson, Zhaohui Gu, Jack Taunton, Laura J. Janke, Taosheng Chen, Mignon L. Loh, Stephen P. Hunger, Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1657–1671.
https://doi.org/10.1182/bloodadvances.2017011296
Published: 2017
Includes: Supplemental data
Journal Articles

Copy number alterations detected as clonal hematopoiesis of indeterminate potential

Koichi Takahashi, Feng Wang, Hagop Kantarjian, Xingzhi Song, Keyur Patel, Sattva Neelapu, Curtis Gumbs, Latasha Little, Samantha Tippen, Rebecca Thornton, Courtney D. DiNardo, Farhad Ravandi, Carlos Bueso-Ramos, Jianhua Zhang, Xifeng Wu, Guillermo Garcia-Manero, P. Andrew Futreal
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1031–1036.
https://doi.org/10.1182/bloodadvances.2017007922
Published: 2017
Includes: Supplemental data